- This event has passed.
Controversial Cases in Hematologic Malignancies and Hematology – Harvard Medical School
April 29, 2016 - April 30, 2016$300
With several new drug therapies as well as an expansion of our understanding of the biologic heterogeneity of hematologic diseases, there is a need for education in the area of hematologic disorders. This interactive, case-focused course is designed to address challenges faced by community specialists in hematology/oncology and provide a focused update on current best practices in hematologic malignancies and hematology. Attendee interaction is encouraged and promoted through the utilization of an audience response system and the opportunity to submit cases and questions during panel discussions. Faculty from the Massachusetts General Hospital Cancer Center and other leading academic institutions will be available for small group discussion during breaks, reception, and lunch.
This year, each section will begin with a brief introduction highlighting drugs and therapies approved within the last year. New topics will include presentations on white and red blood cell disorders, CNS lymphoma, and the unique infectious disease management issues in oncology and transplant populations. In addition, there will be a presentation highlighting hematologic disorders during pregnancy.
Upon completion of this activity, participants will be able to:
- Manage complex coagulation cases in an era of expanding therapeutics through knowledge of evolving treatment options
- Develop strategies to select appropriate therapy among expanding options in hematologic malignancies throughout all phases of patient treatment including upfront management, maintenance therapy, and relapse
- Review major concepts in hematology and hematologic malignancies as assessed by the ABIM Hematology Maintenance of Certification (MOC) Exam
This course is targeted towards specialty physicians, physician assistants, nurse practitioners, fellows and residents who are specializing in oncology and hematology.